ARMISTICE CAPITAL, LLC – Travere Therapeutics, Inc. Transaction History
ARMISTICE CAPITAL, LLC portfolio value:
$143.79M
portfolio value
ARMISTICE CAPITAL, LLC quarter portfolio value change:
+1.69%
quarter
Travere Therapeutics, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +9.70% | 516K shares | 14.89M | $24.64 | 5.83M |
Q2 2022 | share | Increase | +7.30% | 362K shares | 1.13M | $24.23 | 5.32M |
Q1 2022 | share | Increase | +21.58% | 880K shares | 1.18M | $25.77 | 4.95M |
Q4 2021 | share | Decrease | -14.11% | -670K shares | 11.44M | $30.31 | 4.07M |
Q3 2021 | share | Decrease | -17.40% | -1M shares | 31.27M | $24.25 | 4.74M |
Q2 2021 | share | Increase | +143.97% | 3.39M shares | 25.03M | $14.59 | 5.74M |
Q1 2021 | share | Increase | 0.00% | 2.35M shares | 58.82M | $24.97 | 2.35M |